Isolation of a bovine plasma fibronectin-containing complex which inhibits the expression of bovine leukemia virus p24

Journal of Virology

Volumn 79, Issue 13, 2005, Pages 8164-8170

  Van Den Heuvel, Marianne J ^a   Jefferson, Barbara J ^b   Jacobs, Robert M ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; FIBRONECTIN; PLASMA BLOCKING FACTOR; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B CELL LYMPHOMA; BOVINE LEUKEMIA VIRUS; CELL COMPARTMENTALIZATION; COMPLEX FORMATION; HUMAN T CELL LEUKEMIA VIRUS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONONUCLEAR CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIREMIA; VIRUS EXPRESSION; VIRUS INHIBITION; VIRUS ISOLATION;

ANIMALS; CATTLE; FIBRONECTINS; LEUKEMIA VIRUS, BOVINE; SERUM ALBUMIN, BOVINE; VIRAL CORE PROTEINS; VIRUS REPLICATION;

BOS TAURUS; BOVINAE; BOVINE LEUKEMIA VIRUS; DELTARETROVIRUS; HTLV; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 20744436632     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.13.8164-8170.2005     Document Type: Article

References (28)

1. Bearz, A., G. Tell, A. Colombatti, S. Formisano, and C. Pucillo. 1998. Fibronectin binding promotes a PKC-dependent modulation of NF-kappa B in human T cells. Biochem. Biophys. Res. Commun. 243:732-737.
2. Bozzini, S., V. Falcone, P. G. Conaldi, L. Visai, L. Biancone, A. Dolei, A. Toniolo, and P. Speziale. 1998. Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity. J. Med. Virol. 54:44-53.
3. Brooks, P. A., G. L. Cockerell, and J. K. Nyborg. 1998. Activation of BLV transcription by NF-kappa B and Tax. Virology 243:94-98.
4. Burny, A., C. Bruck, Y. Cleuter, D. Couez, J. Deschamps, D. Gregoire, J. Ghysdael, R. Kettmann, M. Mammerickx, and G. Marbaix. 1985. Bovine leukaemia virus and enzootic bovine leukosis. Onderstepoort. J. Vet. Res. 52:133-144.
5. Burny, A., Y. Cleuter, R. Kettmann, M. Mammerickx, G. Marbaix, D. Portetelle, A. Van den Broeke, L. Willems, and R. Thomas. 1987. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv. 6:139-159.
6. Cornil, I., and D. Levy. 1989. In vivo inhibition of bovine leukemia virus (BLV) expression. Leukemia 3:159-161.
7. Derse, D. 1987. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. J. Virol. 61:2462-2471.
8. Derse, D. 1988. trans-acting regulation of bovine leukemia virus mRNA processing. J. Virol. 62:1115-1119.
9. Doonan, S. 1996. Bulk purification by fractional precipitation, p. 135-144. In S, Doonan (ed.), Protein purification protocols. Humana Press, Totowa, N.J.
10. Ferrer, J. F. 1980. Bovine lymphosarcoma. Adv. Vet. Sci. Comp. Med. 24:1-68.
11. ffrench-Constant, C. 1995. Alternative splicing of fibronectin-many different proteins but few different functions. Exp. Cell Res. 221:261-271.
12. Gallo, R. C., and L. S. Nerurkar. 1989. Human retroviruses: their role in neoplasia and immunodeficiency. Ann. N. Y. Acad. Sci. 567:82-94.
13. Girard, D., Y. Raymond, P. Labbe, and J. L. Senecal. 1995. Characterization of a novel human antibody xenoreactive with fibronectin. Clin. Immunol. Immunopathol. 77:149-161.
14. Gupta, P., and J. F. Ferrer. 1982. Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle. Science 215:405-407.
15. Gupta, P., S. V. S. Kashmiri, and J. F. Ferrer. 1984. Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle. J. Virol. 50:267-270.
16. Haas, L., T. Divers, and J. W. Casey. 1992. Bovine leukemia virus gene expression in vivo. J. Virol. 66:6223-6225.
17. Jensen, W. A., J. Rovnak, and G. L. Cockerell. 1991. In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep. J. Virol. 65:2484-2490.
18. Kettmann, R., G. Marbaix, Y. Cleuter, D. Portetelle, M. Mammerickx, and A. Burny. 1980. Genomic integration of bovine leukemia provjrus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk. Res. 4:509-519.
19. Lee, T. H., J. E. Coligan, J. G. Sodroski, W. A. Haseltine, S. Z. Salahuddin, F. Wong-Staal, R. C. Gallo, and M. Essex. 1984. Antigens encoded by the 3′-terminal region of human T-cell leukemia virus: evidence for a functional gene. Science 226:57-61.
20. Miller, J. M., L. D. Miller, C. Olson, and K. G. Gillette. 1969. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J. Natl. Cancer Inst. 43:1297-1305.
21. Retta, S. F., P. Ferraris, and G. Tarone. 1999. Purification of fibronectin from human plasma. Methods Mol. Biol. 96:119-124.
22. Slamon, D. J., K. Shimotohno, M. J. Cline, D. W. Golde, and I. S. Chen. 1984. Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science 226:61-65.
23. Stock, N. D., and J. F. Ferrer. 1972. Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin. J. Natl. Cancer Inst. 48:985-996.
24. Taylor, J. A., and R. M. Jacobs. 1993. Effects of plasma and serum on the in vitro expression of bovine leukemia virus. Lab. Investig. 69:340-346.
25. Tsukiyama, K., M. Onuma, and H. Izawa. 1987. Effect of platelet-derived factor on expression of bovine leukemia virus genome. Arch. Virol. 96:89-96.
26. van den Heuvel, M., D. Portetelle, B. Jefferson, and R. M. Jacobs. 2003. Adaptation of a sandwich enzyme-linked immunosorbent assay to determine the concentration of bovine leukemia virus p24 and optimal conditions for p24 expression in short-term cultures of peripheral blood mononuclear cells. J. Virol. Methods 111:61-67.
27. Zandomeni, R. O., M. Carrera-Zandomeni, E. Esteban, W. Donawick, and J. F. Ferrer. 1992. Induction and inhibition of bovine leukaemia virus expression in naturally infected cells. J. Gen. Virol. 73:1915-1924.
28. Zandomeni, R. O., E. Esteban, M. Carrera-Zandomeni, and J. F. Ferrer. 1994. Host soluble factors with blocking and stimulating activity on the expression of the bovine leukemia virus. J. Infect. Dis. 170:787-794.